How effective is Ambien for Narcolepsy? (a real world drug study)
Summary:
Overall ratings: 3.7/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Ambien (zolpidem tartrate) is for Narcolepsy and for what kind of people. The study is created by eHealthMe from 7 Ambien users and is updated continuously.
What is Ambien?
Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.
What is Narcolepsy?
Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 425 drugs and 738 conditions by eHealthMe. Check the latest studies of Narcolepsy.
7 people are studied for taking Ambien in Narcolepsy
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Ambien effectiveness for Narcolepsy (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 2
- high: 2
- very high: 2
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 1
- high: 2
- very high: 1
Gender of people who take Ambien for Narcolepsy *:
- female: 85.71 %
- male: 14.29 %
Age of people who take Ambien for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 14.29 %
- 30-39: 57.14 %
- 40-49: 14.29 %
- 50-59: 14.29 %
- 60+: 0.0 %
Who find Ambien more effective for Narcolepsy?
Gender of people who take Ambien for Narcolepsy *:
- female: 75 %
- male: 25 %
Age of people who take Ambien for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Ambien?
- You can start a phase IV clinical trial to monitor Ambien safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Ambien (93,519 reports)
Treatments, associated drugs and conditions:
- Narcolepsy (79,888 reports)
How the study uses the data?
The study is based on zolpidem tartrate (the active ingredients of Ambien) and Ambien (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sepsis and drugs of ingredients of erenumab-aooe - 3 seconds ago
- Otitis Media and drugs of ingredients of dapsone - 11 seconds ago
- Flovent and Urinary Tract Infection for Men aged 60+ - 14 seconds ago
- Calcium Carbonate and Hypokalemic Syndrome for Men aged 50-59 - 15 seconds ago
- Flovent and Uti for Men aged 60+ - 15 seconds ago
- Calcium Carbonate and Hypokalaemic Syndrome for Men aged 50-59 - 15 seconds ago
- Flovent and Bladder Infection for Men aged 60+ - 15 seconds ago
- Calcium Carbonate and Hypopotassemia for Men aged 50-59 - 16 seconds ago
- Flovent and Cystitis for Men aged 60+ - 16 seconds ago
- Calcium Carbonate and Hypokalaemia for Men aged 50-59 - 16 seconds ago